Leukotriene B4 ω-side chain hydroxylation by CYP4F5 and CYP4F6

被引:26
作者
Bylund, J
Harder, AG
Maier, KG
Roman, RJ
Harder, DR
机构
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA
关键词
cytochrome p450; hydroxylase; northern blots; 18-hydroxy-LTB4; 19-hydroxy-LTB4; microsomes;
D O I
10.1016/S0003-9861(03)00030-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukotriene B-4 (LTB4) is a lipid mediator that plays an important role in inflammation. Metabolism of LTB4 by cytochrome P450 (CYP) enzymes belonging to the CYP4F subfamily is considered to be of importance for the regulation of inflammation. This study investigates LTB4 metabolism by recombinant rat CYP4F5 and CYP4F6 expressed in a yeast system and by microsomes isolated from rat organs expressing CYP4F mRNA. CYP4F6 was found to convert LTB4 into 19-hydoxy- and 18-hydroxy-LTB4 with an apparent K-m of 26 muM, and CYP4F5 was found to convert LTB4 primarily into 18-hydroxy-LTB4 with an apparent K-m of 9.7 muM. The rate of formation of 18-hydroxy-LTB4 by CYP4F5 was surprisingly high. At a substrate concentration of 30 muM, the rate of formation was about 15 nmol/min/mg microsomal protein, approximately 30 times faster than the reaction catalyzed by CYP4F6. Analysis of LTB4 metabolism by microsomes isolated from various tissues from the rat suggests that CYP4F5 and CYP4F6 are active in the lung and to some extent in the brain, kidney, and testis. CYP4F5 and CYP4F6, due to their capacities to metabolize LTB4, may play important roles in modulating inflammatory response in these organs. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 26 条
[1]   Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes [J].
Alkayed, NJ ;
Narayanan, J ;
Gebremedhin, D ;
Medhora, M ;
Roman, RJ ;
Harder, DR .
STROKE, 1996, 27 (05) :971-979
[2]   ETHANOL-INDUCED INHIBITION OF LEUKOTRIENE DEGRADATION BY OMEGA-OXIDATION [J].
BAUMERT, T ;
HUBER, M ;
MAYER, D ;
KEPPLER, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 182 (02) :223-229
[3]   Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography mass spectrometry with ion trap MS2 [J].
Bylund, J ;
Ericsson, J ;
Oliw, EH .
ANALYTICAL BIOCHEMISTRY, 1998, 265 (01) :55-68
[4]   Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides [J].
Bylund, J ;
Hidestrand, M ;
Ingelman-Sundberg, M ;
Oliw, EH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :21844-21849
[5]   IDENTIFICATION OF A NEW P450 SUBFAMILY, CYP4F1, EXPRESSED IN RAT HEPATIC-TUMORS [J].
CHEN, LP ;
HARDWICK, JP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 300 (01) :18-23
[6]  
Christmas P, 2001, J BIOL CHEM, V276, P38166
[7]   OXIDATION OF LEUKOTRIENES AT THE OMEGA-END - DEMONSTRATION OF A RECEPTOR FOR THE 20-HYDROXY DERIVATIVE OF LEUKOTRIENE-B-4 ON HUMAN-NEUTROPHILS AND IMPLICATIONS FOR THE ANALYSIS OF LEUKOTRIENE RECEPTORS [J].
CLANCY, RM ;
DAHINDEN, CA ;
HUGLI, TE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (18) :5729-5733
[8]  
DAHINDEN CA, 1984, J IMMUNOL, V133, P1477
[9]  
Hankin JA, 1998, J PHARMACOL EXP THER, V285, P155
[10]   Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats [J].
Kalsotra, A ;
Anakk, S ;
Boehme, CL ;
Strobel, HW .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (09) :1022-1028